Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.134

-0.007 (-5.24%)

At close: Apr 28, 2026, 4:00 PM EDT

0.139

+0.005 (3.81%)

After-hours: Apr 28, 2026, 7:12 PM EDT

Virax Biolabs Group Employees

Virax Biolabs Group had 19 employees as of March 31, 2025. The number of employees increased by 2 or 11.76% compared to the previous year.

Employees

19

Change (1Y)

2

Growth (1Y)

11.76%

Revenue / Employee

$157

Profits / Employee

-$297,031

Market Cap

2.67M

Employees Chart

Employees History

Date	Employees	Change	Growth
Mar 31, 2025	19	2	11.76%
Mar 31, 2024	17	6	54.55%
Mar 31, 2023	11	6	120.00%
Mar 31, 2022	5	-	-

Related Stocks

Company Name	Employees
Scinai Immunotherapeutics	31
GeoVax Labs	17
Silexion Therapeutics	14
Azitra	13
Decoy Therapeutics	11
Ensysce Biosciences	10
Artelo Biosciences	7
GRI Bio	4

Employee Rankings

VRAX News

14 days ago - Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders - PRNewsWire
4 weeks ago - What's Behind The Jump In Virax Biolabs Stock? - Benzinga
4 weeks ago - Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation - PRNewsWire
5 months ago - Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement - PRNewsWire
5 months ago - Virax Biolabs Group Limited Announces $5 Million Private Placement - PRNewsWire
5 months ago - Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders - PRNewsWire
6 months ago - Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes - PRNewsWire
8 months ago - Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September - PRNewsWire